Effect of Oral PUVAsol on the Quality of Life in Indian Patients Having Chronic Plaque Psoriasis

Table 2

PASI scores in study group at baseline and after 12 weeks of regular treatment.

Study subjects	Pretreatment (baseline)	Posttreatment (after 12 weeks)	value
Total cases; ( = 40)	22.94 ± 9.03	14.16 ± 10.99	0.0002
Patients having lesions at mixed sites ( = 8)	29.38 ± 7.30	24.20 ± 16.09	0.0780
Patients having lesions at unexposed sites ( = 32)	19.79 ± 7.03	10.81 ± 5.64	0.0001